SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,192 | -47.6% | 43,358 | +5.5% | 0.00% | – |
| Q2 2023 | $196,851 | -0.9% | 41,096 | +17.3% | 0.00% | – |
| Q1 2023 | $198,603 | +3.7% | 35,027 | +2.4% | 0.00% | – |
| Q4 2022 | $191,486 | -94.8% | 34,194 | -94.0% | 0.00% | -100.0% |
| Q3 2022 | $3,657,000 | +3350.0% | 569,597 | +1752.5% | 0.00% | – |
| Q2 2022 | $106,000 | -52.9% | 30,748 | -3.1% | 0.00% | – |
| Q1 2022 | $225,000 | -14.8% | 31,726 | -0.0% | 0.00% | – |
| Q4 2021 | $264,000 | -6.0% | 31,729 | -21.2% | 0.00% | – |
| Q3 2021 | $281,000 | -65.0% | 40,249 | +19.6% | 0.00% | – |
| Q2 2021 | $802,000 | +167.3% | 33,645 | +131.1% | 0.00% | – |
| Q1 2021 | $300,000 | +18.1% | 14,558 | +40.1% | 0.00% | – |
| Q4 2020 | $254,000 | -87.9% | 10,389 | -86.0% | 0.00% | -100.0% |
| Q3 2020 | $2,093,000 | – | 73,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |